Characterization of the Human Papillomavirus 16 Oncogenes in K14HPV16 Mice: Sublineage A1 Drives Multi-Organ Carcinogenesis
Authors:
- Daniela CochichoDCDaniela Cochicho
- Alexandra NunesANAlexandra Nunes
- João Paulo GomesJoão Paulo Gomes
- Luís MartinsLMLuís Martins
- Mário CunhaMário Cunha
- Beatriz Medeiros-FonsecaBMBeatriz Medeiros-Fonseca
- Paula OliveiraPaula Oliveira
- Margarida M. S. M. BastosMBMargarida M. S. M. Bastos
- Rui MedeirosRui Medeiros
- Joana MendonçaJMJoana Mendonça
- Luis VieiraLVLuis Vieira
- Rui M. Gil da CostaRui M. Gil da Costa
Open Access
- 15 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12371
Abstract
The study of human papillomavirus (HPV)-induced carcinogenesis uses multiple in vivo mouse models, one of which relies on the cytokeratin 14 gene promoter to drive the expression of all HPV early oncogenes. This study aimed to determine the HPV16 variant and sublineage present in the K14HPV16 mouse model. This information can be considered of great importance to further enhance this K14HPV16 model as an essential research tool and optimize its use for basic and translational studies. Our study evaluated HPV DNA from 17 samples isolated from 4 animals, both wild-type (n = 2) and HPV16-transgenic mice (n = 2). Total DNA was extracted from tissues and the detection of HPV16 was performed using a qPCR multiplex. HPV16-positive samples were subsequently whole-genome sequenced by next-generation sequencing techniques. The phylogenetic positioning clearly shows K14HPV16 samples clustering together in the sub-lineage A1 (NC001526.4). A comparative genome analysis of K14HPV16 samples revealed three mutations to the human papillomaviruses type 16 sublineage A1 representative strain. Knowledge of the HPV 16 variant is fundamental, and these findings will allow the rational use of this animal model to explore the role of the A1 sublineage in HPV-driven cancer.Keywords
Funding Information
- the GenomePT project (POCI-01-0145-FEDER-022184)
- the Fundação para a Ciência e a Tecnologia within the scope of the project (UID/BIM/00009/2019)
- national funds through FCT/MCTES (PIDDAC) (LA/P/0045/2020 (ALiCE), UIDB/00511/2020, UIDP/00511/2020 (LEPABE))
- the Fundação para a Ciência e a Tecnologia within the scope of the project (UID/BIM/00009/2019)
- Norte Portugal Regional Operational Programme (NORTE 2020) (NORTE-01-0145-FEDER-000054)
This publication has 52 references indexed in Scilit:
- HPV16 genetic variation and the development of cervical cancer worldwideBritish Journal of Cancer, 2012
- Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variationsInternational Journal of Cancer, 2012
- Human Papillomavirus (HPV) 16 E6 Variants in Tonsillar Cancer in Comparison to Those in Cervical Cancer in Stockholm, SwedenPLOS ONE, 2012
- Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in miceVirology, 2010
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendmentsVirology, 2010
- Diindolylmethane Inhibits Cervical Dysplasia, Alters Estrogen Metabolism, and Enhances Immune Response in the K14-HPV16 Transgenic Mouse ModelCancer Epidemiology, Biomarkers & Prevention, 2009
- Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesionsJournal of General Virology, 2009
- Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US populationInternational Journal of Cancer, 2009
- Sequence Variation of Human Papillomavirus Type 16 and Measurement of Viral Integration by Quantitative PCRJournal of Clinical Microbiology, 2009
- Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomasOral Oncology, 2004